Interactive Brokers Lifts All Trading Restrictions on Options

 GREENWICH, Conn.-Sunday 31 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Interactive Brokers Group (Nasdaq: IBKR), a global brokerage firm, announced today that on Friday it lifted all trading restrictions on options in AMC, BB, EXPR, GME, KOSS and other options that experienced recent market volatility. The options, as well as the underlying stocks, are currently subject to increased margin requirements, which are subject to change depending on market conditions. The firm continues to monitor these volatile markets.

About Interactive Brokers Group, Inc.:

Interactive Brokers Group affiliates provide automated trade execution and custody of securities, commodities, foreign exchange and their derivative products around-the-clock on over 135 markets in numerous countries and currencies, from a single IBKR Integrated Investment Account to clients worldwide. We service individual investors, hedge funds, proprietary trading groups, financial advisors and introducing brokers. Our four decades of focus on technology and automation has enabled us to equip our clients with a uniquely sophisticated platform to manage their investment portfolios. We strive to provide our clients with advantageous execution prices and trading, risk and portfolio management tools, research facilities and investment products, all at low or no cost, positioning them to achieve superior returns on investments. Barron’s ranked Interactive Brokers #1 with 5 out of 5 stars in its February 24, 2020, Best Online Broker Review.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210130005024/en/

Contacts

Interactive Brokers Group, Inc.
media@ibkr.com

Permalink : https://www.aetoswire.com/news/interactive-brokers-lifts-all-trading-restrictions-on-options/en

PMI Partners with U.S. Department of Homeland Security on Combatting Illicit Trade

 NEW YORK-Saturday 30 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Philip Morris International Inc. (PMI) (NYSE: PM) today signed a memorandum of understanding (MOU) with the National Intellectual Property Rights Coordination Center (IPR Center) at the U.S. Department of Homeland Security (DHS) to assist and support Homeland Security Investigations’ (HSI) illicit tobacco trade operations and other intellectual property rights investigations.

“We are thrilled to partner with DHS and the IPR Center to combat the illicit tobacco trade,” said PMI’s head of illicit trade prevention for the U.S. Hernan Albamonte. “This partnership will provide both parties necessary information to thwart terrorist and criminal organizations that profit from the trade of illicit tobacco and jeopardize our national security.”

The MOU is focused on comprehensive strategies and coordinating efforts to disrupt and combat all forms of illicit tobacco trade, as well as to address vital areas of intellectual property, brand protection, and anti-counterfeiting strategies. The agreement will also facilitate knowledge transfer between the center and PMI to share mutually beneficial information and research to combat the illicit tobacco trade and assist in other intellectual property rights investigations.

“The agreement being signed today, is a continuation of a years-long partnership between the IPR Center and PMI to protect the American public by enforcing the nation’s intellectual property rights laws and educating consumers on the dangers of illicitly traded tobacco products. The IPR Center will leverage this robust public-private partnership to develop outreach, training efforts and share referral information to open investigations and target these criminal acts,” said Steve Francis, IPR Center director.

Following an unprecedented year—when criminal and terrorist organizations swiftly adapted and migrated their operations to suit the new environment—this partnership illustrates how public- and private-sector cooperation can make full use of existing expertise and information sharing to foster innovative solutions and evolving technologies.

In 2020, PMI recognized the urgent need to convene a myriad group of government, diplomatic, public, and private institutions to advance solutions to strengthen national security by upping the fight against illicit products—from illicit tobacco-containing products to faulty personal protective equipment (PPE). These successes include:

Taking tens of thousands of online and offline enforcement actions against IP infringements in the U.S. and globally, including against IP infringing online marketplace listings, social media accounts, and websites.

Working in close cooperation with state and local law enforcement agencies across the U.S. to disrupt online operations illegally distributing tobacco containing products.

Launching a first of its kind, six-week virtual certification course titled “Illicit Trade in Tobacco Products: Convergence with Crime,” comprised of more than 500 registrants representing 133 U.S. law enforcement agencies.

Building sustainable public-private partnerships through initiatives such as:

PMI IMPACT, a first-of-its-kind global initiative to support public, private, and nongovernmental organizations, which has allocated $48 million for the implementation of more than 60 projects in 30 countries to combat illegal trade and related crimes.

A partnership with the California Narcotic Officers’ Association (CNOA), a nonprofit corporation dedicated to providing high-quality training for law enforcement professionals.

Driving more than 346,000 clicks to DHS resources dedicated to helping recognize and report fraudulent PPE goods through a public service campaign—led by PMI and supported by other private industry and academic leaders—to raise awareness about the emerging threat of fraudulent PPE products.

During the signing event at the IPR Center, PMI’s vice president of external affairs J.B. Simko said, “PMI is focused on developing smoke-free alternatives that are a better choice for adults than continued smoking. Our goal is that one day these products will replace combustible cigarettes for good. The illicit trade undermines these efforts by making unregulated products more accessible, so we are determined to do our part to fight it.”

Philip Morris International: Delivering a Smoke-Free Future

Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, and its shareholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products and associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. In addition, PMI ships a version of its IQOS Platform 1 device and its consumables to Altria Group, Inc. for sale under license in the U.S., where the U.S. Food and Drug Administration (FDA) has authorized their marketing as a modified risk tobacco product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI’s smoke-free product portfolio includes heat-not-burn and nicotine-containing vapor products. As of Sept. 30, 2020, PMI estimates that approximately 11.7 million adult smokers around the world have already stopped smoking and switched to PMI’s heat-not-burn product, available for sale in 61 markets in key cities or nationwide under the IQOS brand. For more information, please visit www.pmi.com and www.pmiscience.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210129005550/en/

Contacts

Sam Dashiell

Philip Morris International Media Office

T. +1 (202) 480 1617

E. samuel.dashiell@pmi.com

Permalink : https://www.aetoswire.com/news/pmi-partners-with-us-department-of-homeland-security-on-combatting-illicit-trade/en

Moody’s Launches DataHub, Collating Billions of Data Points for Decision-Makers to Explore and Analyze

 NEW YORK-Saturday 30 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Moody’s Corporation (NYSE:MCO) today announced the launch of Moody’s DataHub, a new cloud-based analytical platform that integrates data from across Moody’s, including its affiliates. Moody’s DataHub enables financial and risk decision-makers to explore, analyze and consume a wide range of relevant information seamlessly and efficiently.

“With Moody’s DataHub, we are bringing our vast assets together to support today’s data science and analytic needs,” said Stephen Tulenko, President of Moody’s Analytics. “Moody’s is helping customers seamlessly analyze financial and nonfinancial information, combining structured and unstructured data to support better decisions.”

Moody’s DataHub provides access to billions of data points to inform more holistic risk management and investment decisions. Coverage includes:

Over 4.5 million active and historical ratings from Moody’s Investors Service

Default and recovery data dating back to 1920 covering more than 800,000 securities and 59,000 issuers

Probabilities of default for more than 60,000 publicly traded firms from Moody’s CreditEdge

Nearly 400 million private and public entities from Bureau van Dijk’s Orbis database

More than 5,000 ESG assessments from V.E, part of Moody’s ESG Solutions Group

Climate risk scores for over 5,000 companies and 200 sovereigns from Four Twenty Seven, part of Moody’s ESG Solutions Group

Over 40 million loans underlying US RMBS, CMBS, and CDO transactions

30-year forecasts of more than 2,100 major macroeconomic variables from Moody’s Analytics U.S. Macro Forecast Database

Moody’s DataHub delivers cross-referenced datasets in a centralized area with sophisticated analytical capabilities. The platform facilitates a holistic view of risks and opportunities related to credit, real estate investments, and climate, and provides essential inputs for Know Your Customer (KYC) onboarding and compliance screening, master data management, and entity resolution.

Easily accessible data previews, along with a readily available data dictionary and documentation, allow users to explore and efficiently interact with Moody’s datasets. Using Moody’s DataHub’s advanced tools, customers can discover and transform data while collaborating in secure environments, blending Moody’s data with their own to create engineered products and services.

“Moody’s DataHub gives customers transparency and control, and the platform was designed to facilitate rigorous data analysis while being straightforward to use,” said Mr. Tulenko. “We will continue to add datasets to the platform and will enhance its analytical capabilities in line with our commitment to deliver market-leading solutions for decision-makers.”

For more information on Moody’s DataHub and a full list of the datasets currently available through the platform, please visit the website.

ABOUT MOODY’S CORPORATION

Moody’s (NYSE:MCO) is a global risk assessment firm that empowers organizations to make better decisions. Its data, analytical solutions and insights help decision-makers identify opportunities and manage the risks of doing business with others. We believe that greater transparency, more informed decisions, and fair access to information open the door to shared progress. With over 11,400 employees in more than 40 countries, Moody’s combines international presence with local expertise and over a century of experience in financial markets. Learn more at moodys.com/about.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005336/en/

Contacts

SHIVANI KAK

Investor Relations

+1 212-553-0298

Shivani.kak@moodys.com

OR

JOE MIELENHAUSEN

Communications

+1 212-553-1461

joe.mielenhausen@moodys.com

Permalink : https://www.aetoswire.com/news/moodyrsquos-launches-datahub-collating-billions-of-data-points-for-decision-makers-to-explore-and-analyze/en

Kioxia Accelerates Analysis of Large-Volume Data in Life Science Research Outcomes

 Findings Have Been Published in the Journal Science

TOKYO-Saturday 30 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Kioxia Corporation is pleased to announce its contribution to the acceleration of large-volume data analysis in the research outcomes described in a new paper "Expansion Sequencing: Spatially Precise In Situ Transcriptomics in Intact Biological Systems", published in the journal Science(1). This acceleration was achieved by building a GPU cluster for life science research equipped with solid-state drives (SSDs) and by developing image analysis algorithms. This research on an RNA sequencing technology was led by the Synthetic Neurobiology Group at the MIT Media Lab and their collaborators, including Kioxia, and the results were obtained by utilizing the GPU cluster for image analysis.

This novel RNA sequencing technology captures multiple microscopy images of the specimen that has been physically expanded using swellable polymers, and identifies RNA sequences through image analysis, thereby maintaining the tissue structure. The image data size becomes terabytes, requiring acceleration of data analysis. By running the image analysis algorithms on the GPU cluster equipped with CM series enterprise SSDs developed by Kioxia, the researchers were able to analyze 10 terabytes of data from a large specimen in a few days, demonstrating the identification of RNA sequences as well as their high-resolution locations within the tissue in mouse brains and a human cancer sample.

Kioxia will continue to conduct research and development on the acceleration of large-volume data processing, and contribute to advancing science and technology by strengthening industry-academia collaboration to foster innovations.

(1) Alon et al. https://science.sciencemag.org/cgi/doi/10.1126/science.aax2656

Please see our website for more information on our research collaboration with the Synthetic Neurobiology Group.

https://about.kioxia.com/en-jp/rd/collaboration/memory-topics01.html

About Kioxia Group

Kioxia is a world leader in memory solutions, dedicated to the development, production and sale of flash memory and solid state drives (SSDs). In April 2017, its predecessor Toshiba Memory was spun off from Toshiba Corporation, the company that invented NAND flash memory in 1987. The company pioneers cutting-edge memory solutions and services that enrich people's lives and expand society's horizons. Kioxia's innovative 3D flash memory technology, BiCS FLASH™, is shaping the future of storage in high-density applications, including advanced smartphones, PCs, SSDs, automotive and data centers.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128006221/en/

Contacts

For More Information

Public Relations

Kota Yamaji (kioxia-hd-pr@kioxia.com)

Kioxia Holdings Corporation

Permalink : https://www.aetoswire.com/news/kioxia-accelerates-analysis-of-large-volume-data-in-life-science-research-outcomes/en

French Ministry of the Interior Selects IDEMIA and Sopra Steria to Develop a New Standard Border Control System

 • The French Ministry of the Interior has selected the IDEMIA and Sopra Steria consortium to design, build, roll out, maintain and update a new standard border control system (CCAF).

• The CCAF rollout will form part of the EU’s 2022 introduction of its Entry-Exit System (EES), which is intended to better secure the Schengen Area’s outside borders and most of all, to tackle the issue of foreign nationals overstaying their visas.

• Biometric technologies underpinning the CCAF will help make border controls faster and more accurate.

COURBEVOIE, France-Saturday 30 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- CCAF is an ambitious project seeking to install a high-performance standard system so that all border control activities can be properly coordinated and harmonized. It will be rolled out in France during 2021.

While assuring border controls’ underlying need for security and accuracy, CCAF’s development will also focus on interoperability and scalability. It will be so designed that it can cope with future French and EU regulatory changes and growth in traveller traffic in and out of mainland and overseas France.

Underpinned by biometric recognition, the system will minimize traveller time spent passing through border controls without having to hire further guards on French borders.

IDEMIA and Sopra Steria will join forces tapping into their ID management expertise, especially in relation to border security, and their French critical systems in-depth know-how.

There is a lot at stake with the CCAF project including a need to factor in high flexibility and responsiveness when developing EU IT systems in view of upcoming world sports events like the 2023 Rugby World Cup and the 2024 Paris Olympics. With this joint project, the Ministry placed their trust in the consortium’s skill and expertise in meeting highly demanding business, tech and regulatory needs and tight milestone deadlines.

“We are very grateful to the French Ministry of the Interior for having trusted our know-how and expertise in automated border-crossing controls. The CCAF project aims to develop and perfect a standard and robust border system that is both smoother and more secure. Together with our partner Sopra Steria, we pledge to provide a groundbreaking system that delivers a high level of security and an enhanced travel experience.” said Pascal Fallet, IDEMIA Senior VP Europe, Public Security and Identity.

“Having served the Ministry of the Interior over many years, we are immensely proud to be selected with our partner IDEMIA to develop and roll out the new standard border control system. IDEMIA’s skills and know-how as biometrics world leader fit very well with our own skills as reputed big government systems integrator in complex environments. This will be a great asset to ensure the project’s success. Together with IDEMIA we pledge to develop a reliable and secure system that sustainably delivers on required service quality by harnessing all necessary state-of-the-art technologies.” said Georges Wakim, Sopra Steria Security Market Director.

In France, IDEMIA is currently responsible for the passenger automated border control tracking system and the visa and asylum application data processing system. IDEMIA also regularly conducts pilot tests with various private and public sector parties including Aéroports de Paris (ADP Group), Air France and recently Lyon Aéroports (MONA by Vinci Airports) with a view to biometrics improving the airport’s passenger experience.

Meanwhile, Sopra Steria frequently serves the French Ministry of the Interior bringing many famous projects to fruition. For instance, the Group helps develop the Schengen border system working with various other EU Member States, develops and delivers security file search apps for French police forces and works to enhance French road safety and management of foreign migrants.

Last June, IDEMIA and Sopra Steria were picked by EU agency eu-LISA to develop the new shared Biometric Matching System (sBMS), on which Schengen Area border security is based.

About IDEMIA

IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.

Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors. With close to 15,000 employees around the world, IDEMIA serves clients in 180 countries.

For more information, visit www.idemia.com / Follow @IDEMIAGroup on Twitter

About Sopra Steria

Sopra Steria, a European leader in consulting, digital services and software development, helps its clients drive their digital transformation and obtain tangible and sustainable benefits. It provides end-to-end solutions to make large companies and organisations more competitive by combining in-depth knowledge of a wide range of business sectors and innovative technologies with a fully collaborative approach. Sopra Steria places people at the heart of everything it does and is committed to putting digital to work for its clients in order to build a positive future for all. With 46,000 employees in 25 countries, the Group generated revenue of €4.4 billion in 2019.

The world is how we shape it.

Sopra Steria (SOP) is listed on Euronext Paris (Compartment A) – ISIN: FR0000050809

To learn more, go to https://www.soprasteria.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005909/en/

Contacts

Press contacts

IDEMIA:

Hanna SEBBAH

idemia@havas.com

+33 (0) 6 63 73 30 30

Sopra Steria :

Elsa ESTAGER

elsa.estager@soprasteria.com

Permalink : https://www.aetoswire.com/news/french-ministry-of-the-interior-selects-idemia-and-sopra-steria-to-develop-a-new-standard-border-control-system/en

Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma

 OSAKA, Japan-Saturday 30 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select products sold in Latin America to Hypera S.A. (“Hypera Pharma”) for a total value of $825 million USD. This divestment agreement was first announced in March 2020.

The divested portfolio includes select over-the-counter and prescription pharmaceutical products sold in Brazil, Mexico, and other South American, Central American and Caribbean countries, which are part of Takeda’s Growth & Emerging Markets Business Unit (GEM BU). The products, while addressing key patient needs in these countries, are outside of the business areas Takeda has designated as core to its global long-term growth.

Close to 300 Takeda commercial employees will transition with the divested portfolio at close. As part of a manufacturing and supply agreement, Takeda will continue to exclusively manufacture the divested products.

Takeda intends to use the proceeds from the sale to reduce its debt and accelerate deleveraging towards its target of 2x net debt/adjusted EBITDA within Fiscal Years 2021–2023.

Takeda exceeded its $10 billion non-core asset divestiture target in 2020, announcing 11 deals since January 2019 to date for a total aggregate value of up to approximately $11.6 billion.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline.

Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.

For more information, visit https://www.takeda.com.

Important Notice

For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.

The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we,” “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.

Forward-Looking Statements

This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets,” “plans,” “believes,” “hopes,” “continues,” “expects,” “aims,” “intends,” “ensures,” “will,” “may,” “should,” “would,” “could” “anticipates,” “estimates,” “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations; the success of or failure of product development programs; decisions of regulatory authorities and the timing thereof; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/reports/sec-filings/ or at www.sec.gov. Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210129005591/en/

Contacts

Japanese Media

Kazumi Kobayashi

kazumi.kobayashi@takeda.com

+81 (0) 3-3278-2095

Investor Relations:

Christopher O’Reilly

takeda.ir.contact@takeda.com

+81 (0) 3-3278-2306

Media outside Japan

Justine Grosvenor

justine.grosvenor@takeda.com

+1 872 226 6701

Permalink : https://www.aetoswire.com/news/takeda-completes-sale-of-select-otc-and-non-core-assets-to-hypera-pharma/en

Palantir Technologies and Rio Tinto Sign Multi-Year Enterprise Partnership

 DENVER-Friday 29 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Palantir Technologies Inc. (NYSE:PLTR) announced today it has signed a multi-year enterprise agreement for its Foundry Platform with Rio Tinto (ASX:RIO), one of the world’s leading mining and metals corporations.

Palantir’s software will integrate raw data from a multitude of disparate sources into a representation of critical mining operations. Rio Tinto will be able to make decisions and take actions using a single source of truth that combines operational and transactional data. This data resource will be available, with the necessary security and privacy controls, to its frontline and office-based workers.

“This partnership is an important step in our digital transformation; enabling fast-paced, forward-looking decision making across our operations leading to improved results in safety, cost and production,” says Fay Cranmer, Rio Tinto’s CIO. “We are excited to work with Palantir in the collaborative delivery of digital products, with best-in-class data technology.”

The new multi-year partnership with Rio Tinto builds on a number of successful data integration projects explored last year across various business units including: transforming Borates to a digital business across the value chain; connecting people with data in Rio Tinto’s underground operations; and assisting the company with the safety and well-being of its employees during the COVID-19 pandemic.

“This is a significant industry partnership for us”, says Shyam Sankar, COO of Palantir. “Our Foundry Platform has been used extensively to accelerate delivery and optimise value chains across a number of market sectors where safety matters.”

About Palantir

Palantir Technologies Inc. is a software company that builds enterprise data platforms for use by organizations with complex and sensitive data environments. From building safer cars and planes, to discovering new drugs and combating terrorism, Palantir helps customers across the public, private, and non-profit sectors transform the way they use their data. Additional information is available at www.palantir.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir’s expectations regarding the amount and the terms of the contract and the expected benefits of our software platforms. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include our ability to meet the unique needs of our customer; the failure of our platforms to satisfy our customer or perform as desired; the frequency or severity of any software and implementation errors; our platforms’ reliability; and our customer’s ability to modify or terminate the contract. Additional information regarding these and other risks and uncertainties is included in the filings we make with the Securities and Exchange Commission from time to time. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005373/en/

Contacts

Lisa Gordon

media@palantir.com

Permalink : https://www.aetoswire.com/news/palantir-technologies-and-rio-tinto-sign-multi-year-enterprise-partnership/en

Fluor Unveils New Strategic Priorities and Goals to Support Building a Better Future

 IRVING, Texas-Saturday 30 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Fluor Corporation (NYSE: FLR) unveiled today its new strategy to become the preeminent leader of professional and technical solutions at its 2021 Strategy Day called “Building a Better Future.”

“My top priority since being named Fluor’s CEO has been to work closely with the Board and the management team to develop a strategy that addresses the mega trends that are impacting how we do business,” said David Constable, chief executive officer. “With an emphasis on sustainable outcomes and creating shareholder value, our new strategy leverages our world-class expertise and rewards Fluor for the value we provide while improving our financial position and creating a fit-for-purpose organization.”

At the Strategy Day event, Fluor’s leadership team outlined the four strategic priorities for driving value creation:

Drive growth across Fluor’s portfolio – By 2023, Fluor expects 70 percent of revenue will come from non-traditional oil and gas segments.

Pursue contracts with fair and balanced terms – Fluor will improve the quality of its backlog by only pursuing and executing work with fair and balanced terms. Fluor’s backlog will be more than 75 percent reimbursable by 2024, which is similar to historical norms.

Reinforce financial discipline – By 2024, Fluor plans to lower and maintain a debt to capitalization ratio corridor between 20 to 40 percent, generate return on invested capital in excess of 20 percent, secure investment grade credit ratings and deliver top quartile shareholder returns. Fluor is targeting a 2024 earnings per share range of $3.00 to $3.50.

Foster a high-performance culture with purpose – Fluor is committed to increasing women and diversity in leadership roles and creating a positive and inclusive culture that can drive strong individual and collective performance. In addition, the company has committed to achieve Net Zero for scopes 1 and 2 CO2 equivalent emissions by the end of 2023.

Fluor’s new strategic priorities build upon the previously announced realigning of its operations into three new business segments: Urban Solutions, Mission Solutions and Energy Solutions. The updated organizational and reporting structure aligns Fluor’s business with identified growth markets, and will be implemented in the first quarter of 2021.

Webcast Replay

To access the replay of today’s virtual strategy day event and presentation materials, visit the company’s website at investor.fluor.com.

About Fluor Corporation

Fluor Corporation (NYSE: FLR) is building a better future by applying world-class expertise to solve its clients’ greatest challenges. Fluor’s 45,000 employees provide professional and technical solutions that deliver safe, well-executed, capital-efficient projects to clients around the world. Fluor is ranked 181 among the Fortune 500 companies. With headquarters in Irving, Texas, Fluor has provided engineering, procurement and construction services for more than 100 years. For more information, please visit www.fluor.com or follow Fluor on Twitter, LinkedIn, Facebook and YouTube.

#corp

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005842/en/

Contacts

Brian Mershon

Media Relations

469.398.7621

Jason Landkamer

Investor Relations

469.398.7222

Permalink : https://www.aetoswire.com/news/fluor-unveils-new-strategic-priorities-and-goals-to-support-building-a-better-future/en

Interactive Brokers Takes Action on Actively Traded Symbols

 GREENWICH, Conn-Friday 29 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Interactive Brokers Group (Nasdaq: IBKR), a global brokerage firm, today announced that as of midday yesterday, it has put AMC, BB, EXPR, GME, and KOSS option trading into liquidation only due to the extraordinary volatility in the markets.

In addition, long stock positions will require 100% margin and short stock positions will require 300% margin until further notice. We do not believe this situation will subside until the exchanges and regulators halt or put certain symbols into liquidation only. We will continue to monitor market conditions and may add or remove symbols as may be warranted.

About Interactive Brokers Group, Inc.:

Interactive Brokers Group affiliates provide automated trade execution and custody of securities, commodities, and foreign exchange around the clock on over 135 markets in numerous countries and currencies, from a single IBKR Integrated Investment Account to clients worldwide. We service individual investors, hedge funds, proprietary trading groups, financial advisors and introducing brokers. Our four decades of focus on technology and automation has enabled us to equip our clients with a uniquely sophisticated platform to manage their investment portfolios. We strive to provide our clients with advantageous execution prices and trading, risk and portfolio management tools, research facilities and investment products, all at low or no cost, positioning them to achieve superior returns on investments. Barron’s ranked Interactive Brokers #1 with 5 out of 5 stars in its February 24, 2020, Best Online Broker Review.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005689/en/

Contacts

Interactive Brokers Group, Inc.

Investors: Nancy Stuebe, 203-618-4070

Media: Kalen Holliday, 203-618-4069 or media@ibkr.com

Permalink : https://www.aetoswire.com/news/interactive-brokers-takes-action-on-actively-traded-symbols/en

Western Union Recognized with Inclusion in 2021 Bloomberg Gender-Equality Index

 DENVER-Friday 29 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Western Union (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today announced that it is one of 380 companies globally included in the 2021 Bloomberg Gender-Equality Index (GEI). The GEI measures gender equality across five pillars: female leadership and talent pipeline, equal pay and gender pay parity, inclusive culture, sexual harassment policies, and pro-women brand. It is Western Union’s second consecutive year appearing in the Index.

“Being recognized in the Bloomberg GEI is testament to Western Union’s passion for and commitment to diversity, equity and inclusion,” said Hikmet Ersek, Western Union’s President and Chief Executive Officer. “As a truly global brand with a diverse and multi-cultural stakeholder base, we have been committed to build an inclusive culture that we believe is critical for our organizational health and innovation power, and ultimately, our performance and the company’s future success.”

The GEI brings transparency to gender-related practices and policies at publicly listed companies, increasing the breadth of environmental, social, governance (ESG) data available to investors. The comprehensive, transparent GEI scoring methodology allows investors to assess company performance and compare across industry peer groups.

“The companies included in the 2021 GEI are expanding the ESG data universe to include gender-related data that investors are demanding today,” said Peter T. Grauer, Bloomberg chairman. “Their commitment to disclosure is making the business case for inclusion and driving transparency in the markets.”

Through disclosure of gender-related metrics using the GEI framework, the firms included in the 2021 GEI have committed to provide a comprehensive look at their investment in workplace gender equality and the communities in which they operate, raising the bar of what should be expected from other companies within the same industry. Western Union was included in this year’s index for scoring at or above a global threshold established by Bloomberg to reflect a high level of disclosure and overall performance across the framework’s five pillars.

Both the framework and the GEI are voluntary and have no associated costs. To learn more please visit the GEI website.

WU-G

About Western Union

The Western Union Company (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. The company's omnichannel platform connects the digital and physical worlds and makes it possible for consumers and businesses to send and receive money and make payments with speed, ease, and reliability. As of the end of September 2020, the Western Union network included over 550,000 retail agent locations offering branded services in more than 200 countries and territories, with the capability to send money to billions of accounts. Additionally, westernunion.com, the fastest-growing channel in 2019, is available in over 75 countries, plus additional territories, to move money worldwide. Western Union moves money for better with our global reach, connecting family, friends, and businesses to enable financial inclusion and support economic growth. For more information, visit www.westernunion.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20210127005358/en/

Contacts

Western Union Global Communications

Claire Treacy

Claire.Treacy@westernunion.com

Bloomberg LP

Veronika Henze

+1-646-324-1596

Vhenze@bloomberg.net

Liidia Liuksila

+1 212-617-5424

Lliuksila@bloomberg.net

Permalink : https://www.aetoswire.com/news/western-union-recognized-with-inclusion-in-2021-bloomberg-gender-equality-index/en

BAI Announces 2020 Global Innovation Award Finalists

 CHICAGO-Saturday 30 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- BAI announced the finalists for the 2020 BAI Global Innovation Awards, the industry’s prestigious awards program that celebrates new and innovative solutions in the financial services industry worldwide.

Now in its tenth year, the BAI Global Innovation Awards recognizes leading financial services organizations on a global scale. This year, the awards drew hundreds of nominations from industry leaders demonstrating how their organizations used innovation to tackle their challenges in creative, impactful ways. Each nomination is evaluated by the Innovation Circle, a panel of global financial services innovation leaders who weigh each submission on originality and impact on consumers, employees, communities and the industry to determine the top innovations of the year.

The 2020 BAI Global Innovation Awards finalists are:

Consumer Products of Services Innovation

Bank Pekao S.A., Poland: PeoPay KIDS

CaixaBank S.A., Spain: HolaBank – Onboarding + mortgageNow

FNB Life, South Africa: Dynamic Life – Home

Meridian Credit Union, Canada: Meridian’s Price Drop

OneConnect Smart Technology Co., Ltd. (Shenzhen), China: Smart Fast Claim

Customer Experience Innovation

Bank of Montreal, Canada: BMO AI Cashflow Prediction

Commonwealth Bank of Australia: Bill Sense

DBS Bank Ltd, Singapore: DBS Chatbot – Guided Conversation

Finicity, United States: Empowering the Customer Through Open Banking & Credit Decisioning

FNB Life, South Africa: We’ve Got You COVI(R)D

Human Capital Innovation

Citizens Financial Group, United States: Jamie Virtual Career Assistant

SberBank, Russia: Employee Digital Care Program

Ziraat Bank, Turkey: Hidden Power of Communication

Internal Process Innovation

CaixaBank S.A., Spain: The New Mobility Section at Now

DenizBank, Turkey: Digital Scorecard

ICICI Bank, India: OPTIMUS – Payment Invoicing and ID Card Issuance System

OneConnect Smart Technology Co., Ltd. (ShenZhen), China: Smart Contract Cloud Platform

SberBank, Russia: Contact Center Internal Improvement Process

Marketing Innovation

Emirates NBD Bank, United Arab Emirates: Emirates NBD Anti-Phishing "It Wasn't Me" Campaign

imaginTech S.A., Spain: New imagin, a New Way to Communicate

Synchrony, United States: Millie: A Multi-Channel Personal Finance Platform for Women

RegTech Innovation

Abu Dhabi Global Market Financial Center (ADGM), United Arab Emirates: ADGM and ClauseMatch collaborate to launch Regulation 2.0

Fino Payments Bank, India: Enterprise Risk & Fraud Management solution

KAL ATM Software, Germany: New approach to costly and disruptive ATM hardware upgrades

Ping An Technology (Shenzhen) Co., Ltd., China: Pingan Beehive Federated Intelligence Platform

Small Business Products or Services Innovation

Aliasware, Inc., United States: PayVus Small Business Credit Card

Banco Bradesco, Brazil: Open Banking Initiative: Portal MEI, Solutions for the Individual Micro Entrepreneur

İşbank, Turkey: TekCap

RBC Ventures, Canada: Ownr

Societal and Community Impact Innovation

Citi Ventures Studio, United States: City Builder

Union Bank of the Philippines: UBX SeekCap

Woodforest National Bank, United States: Woodforest CEI-Boulos Opportunity Fund

Congratulations to all the finalists of the 2020 BAI Global Innovation Awards. The winners will be announced in February. To learn more please visit BAI Global Innovation Awards.

About BAI

As a nonprofit, independent organization, BAI has delivered the financial services industry’s most actionable insights for more than 95 years, enabling leaders to make smart business decisions every day. We provide in-depth, proprietary research to more than 40 of the top US banks, support more than 2,100 financial services organizations with compliance and professional development training, provide trusted, relevant thought leadership through BAI Banking Strategies reports, podcasts and webinars, and offer specialized events and programs. For more information, visit www.bai.org.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005646/en/

Contacts

Holly Hughes

BAI, Chicago

hhughes@bai.org

+1 (312) 683-2305

Permalink : https://www.aetoswire.com/news/bai-announces-2020-global-innovation-award-finalists/en

83% of Oracle Database Licensees Cite Vendor Support Costs as Excessive or Too Much; Burdensome Updates and Poor Vendor Support Among Top Challenges in Survey

 Oracle Database licensees may consider using third-party support to provide better, more cost-efficient support and extend the lifespan of current releases

LAS VEGAS-Saturday 30 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Rimini Street, Inc. (Nasdaq: RMNI), a global provider of business software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today disclosed findings from its survey of Oracle Database licensees conducted to understand their top challenges, priorities and strategies in regard to their Oracle Database landscape and usage.

Cost is Top Challenge with Oracle Database

When asked what the top three challenges with Oracle Database were overall, cost was the #1 challenge cited by an overwhelming 97% of survey respondents. License compliance came in at #2 with 51% and “regular updates to maintain support” from the vendor was challenge #3 identified by 50% of the respondents. Additional challenges noted include “security and the cost and effort to apply security patches” (42%), “maintaining performance/availability” (34%) and “poor support from Oracle” (21%). When specifically asked about the cost of vendor support, nearly 83% of respondents noted that Oracle Database support and maintenance costs are excessive or that they are paying too much. 73% of respondents feel they are not getting enough or any valuable database enhancements to justify the cost of support from Oracle.

Oracle Database Licensees Seek Options to Manage Costs and Extend Lifespan

With the high cost of Oracle Database support amid tight IT budgets and limited resources, companies are seeking better, more cost-efficient alternatives for managing their Oracle Database strategy, including deferring major database upgrades, switching to third-party support and adopting open-source options over time. For example, Oracle Database licensee Rent-A-Center found such a solution with Rimini Street Support.

“We have many instances of Oracle Database and were struggling to keep up expensive and disruptive upgrade cycles – not only that, but when we peeled back the onion on our maintenance contract, we realized the available enhancements did not offer significant ROI to our business specifically and the required upgrades just to maintain support simply did not justify the high cost,” said Juan Rajani, director, IT Application Services, Rent-A-Center. “We switched to Rimini Street Support to better maximize our mission-critical database system which the business heavily relies on, and we now receive a much higher, ultra-responsive quality of support – it’s like night and day.”

Survey respondents cited they are considering or are moving to open source databases (35%) or non-Oracle Cloud databases (34%) where possible because of lower costs and/or quicker development as part of their overall Oracle Database strategy. For those survey respondents who are looking at open source databases specifically, the most popular options were PostgreSQL, MySQL and MongoDB.

The survey underscores that a large percentage of respondents (41%) have adopted the strategy to actively reduce their Oracle Database footprint over time. Of those respondents whose database strategy includes reducing their Oracle footprint, their #1 reason for doing so is the high total cost of their Oracle Database deployment (nearly 45%), which includes the cost of licensing, supporting and maintaining, upgrading and patching their database instances.

Many Oracle Database Releases No Longer Fully Supported After 2020

At least 73% of the survey respondents were running either Oracle Database releases that would become no longer fully supported by Oracle in December 2020 or that were already in Sustaining Support at that time (or they didn’t know). This suggests a trend toward maximizing the lifespan and value of currently licensed database releases, with third-party support as an enabling solution option in many cases. Currently, Oracle Database release 11.1 is in Sustaining Support, and Oracle Database release 11.2 recently entered Sustaining Support at the end of December 2020.

“The survey results suggest that most Oracle Database licensees are frustrated with high annual maintenance fees and costly forced upgrades under Oracle support, and are seeking better options for managing their Oracle Database strategy and landscape,” said Frank Reneke, group vice president and general manager, Oracle Services. “Rimini Street helps Oracle licensees maximize the return on their Oracle Database investment by extending the lifespan of current releases, significantly reducing annual maintenance costs and not requiring unnecessary upgrades to maintain full support.”

To access a copy of Rimini Street’s report, “Survey Report: Licensees’ Insights into the Value of Oracle Database and Support,” click here. You can find more information on Rimini Street Support for Oracle Database here.

About Rimini Street, Inc.

Rimini Street, Inc. (Nasdaq: RMNI) is a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner. The Company offers premium, ultra-responsive and integrated application management and support services that enable enterprise software licensees to save significant costs, free up resources for innovation and achieve better business outcomes. To date, more than 3,700 Fortune 500, Fortune Global 100, midmarket, public sector and other organizations from a broad range of industries have relied on Rimini Street as their trusted application enterprise software products and services provider. To learn more, please visit http://www.riministreet.com, follow @riministreet on Twitter and find Rimini Street on Facebook and LinkedIn.

Forward-Looking Statements

Certain statements included in this communication are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may,” “should,” “would,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “seem,” “seek,” “continue,” “future,” “will,” “expect,” “outlook” or other similar words, phrases or expressions. These forward-looking statements include, but are not limited to, statements regarding our expectations of future events, future opportunities, global expansion and other growth initiatives and our investments in such initiatives. These statements are based on various assumptions and on the current expectations of management and are not predictions of actual performance, nor are these statements of historical facts. These statements are subject to a number of risks and uncertainties regarding Rimini Street’s business, and actual results may differ materially. These risks and uncertainties include, but are not limited to, the duration of and operational and financial impacts on our business of the COVID-19 pandemic and related economic impact, as well as the actions taken by governmental authorities, clients or others in response to the COVID-19 pandemic; catastrophic events that disrupt our business or that of our current and prospective clients, changes in the business environment in which Rimini Street operates, including inflation and interest rates, and general financial, economic, regulatory and political conditions affecting the industry in which Rimini Street operates; adverse developments in pending litigation or in the government inquiry or any new litigation; our need and ability to raise additional equity or debt financing on favorable terms and our ability to generate cash flows from operations to help fund increased investment in our growth initiatives; the sufficiency of our cash and cash equivalents to meet our liquidity requirements; the terms and impact of our outstanding 13.00% Series A Preferred Stock; changes in taxes, laws and regulations; competitive product and pricing activity; difficulties of managing growth profitably; the customer adoption of our recently introduced products and services, including our Application Management Services (AMS), Rimini Street Advanced Database Security, and services for Salesforce Sales Cloud and Service Cloud products, in addition to other products and services we expect to introduce in the near future; the loss of one or more members of Rimini Street’s management team; uncertainty as to the long-term value of Rimini Street’s equity securities; and those discussed under the heading “Risk Factors” in Rimini Street’s Quarterly Report on Form 10-Q filed on November 5, 2020, and as updated from time to time by Rimini Street’s future Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings by Rimini Street with the Securities and Exchange Commission. In addition, forward-looking statements provide Rimini Street’s expectations, plans or forecasts of future events and views as of the date of this communication. Rimini Street anticipates that subsequent events and developments will cause Rimini Street’s assessments to change. However, while Rimini Street may elect to update these forward-looking statements at some point in the future, Rimini Street specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Rimini Street’s assessments as of any date subsequent to the date of this communication.

© 2021 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005009/en/

Contacts

Michelle McGlocklin

Rimini Street, Inc.

+1 925 523-8414

mmcglocklin@riministreet.com

Permalink : https://www.aetoswire.com/news/83-of-oracle-database-licensees-cite-vendor-support-costsnbspas-excessive-or-too-much-burdensome-updates-and-poor-vendor-support-among-top-challenges-in-survey/en

L&T Technology Services Wins 2021 BIG Innovation Awards, USA

 LTTS recognized in the “Product” Category for its innovative healthcare and smart campus solutions - Chest rAI™ & i-BEMS

BENGALURU, India-Saturday 30 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a leading global pure-play engineering services company, announced that two of its digital solutions have been recognized with the 2021 BIG Innovation Awards in the “Product” category presented by the Business Intelligence Group, USA.

LTTS has been recognized for its innovative products - Chest rAI™, LTTS’ AI based chest X-Ray analysis system to assist radiologists in improving speed and accuracy of diagnosis and LTTS’ proprietary building automation framework, i-BEMS that operates as an enterprise IoT solution and unifies all campus operations under one system.

There is an acute shortage of radiologists across the globe, leading to delayed interpretation & decision and thus longer wait time for patients. The AI-assisted solution from LTTS assists radiologists by fast triaging abnormalities in X-Ray, annotating and automatic report generation. LTTS has been lauded for creating a product that will benefit millions.

LTTS has also been recognized for contextualizing its offering to suit the ‘new normal’ scenario and create a new module, i-BEMS Shield for a safer workplace environment. i-BEMS, LTTS’ smart building solutions for a post-COVID future - enables features such as automated temperature detection, monitoring of building air quality, and smart maintenance of social distancing norms.

Maria Jimenez, Chief Operating Officer of the Business Intelligence Group, USA said, “The pandemic has made mankind realize the true potential of technology in positively influencing our lives like never before. The world has witnessed some of the best of innovations in the last few months including democratization of access to new-age medical technologies. The role of engineering services in these disruptions is commendable and we value the consistent contributions made by LTTS on this front.”

Dr Keshab Panda, CEO & Managing Director at L&T Technology Services said, “We are pleased to receive the prestigious BIG Innovation Award, which is a true testament to the exemplary work done by LTTS engineers for our global customers. With a formidable digital portfolio that includes over 550 technology patents, LTTS is continually blending ideas and innovations with investments in new age technologies to deliver differentiated engineering solutions uniquely designed to address complex real-life problems faced by the industry. Having joined hands with leading lights of the academic world to create innovations such as the Chest X-Ray analysis system, LTTS believes in creating an ecosystem of excellence to continue engineering the change for the benefit of society.”

The BIG Innovation Awards, recognizes organizations and people who bring new ideas to life from companies across the globe, are judged by a panel of experts which include a select group of business leaders and senior industry executives.

About L&T Technology Services Ltd

L&T Technology Services Limited (LTTS) is a listed subsidiary of Larsen & Toubro Limited focused on Engineering and R&D (ER&D) services. We offer consultancy, design, development and testing services across the product and process development life cycle. Our customer base includes 69 Fortune 500 companies and 53 of the world’s top ER&D companies, across industrial products, medical devices, transportation, telecom & hi-tech, and the process industries. Headquartered in India, we have over 16,000 employees spread across 17 global design centers, 28 global sales offices and 62 innovation labs as of December 31, 2020.

For more information please visit https://www.ltts.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128006004/en/

Contacts

Aniruddha Basu

L&T Technology Services Limited

E: Aniruddha.Basu@LTTS.com

T: +91-80-67675707

Permalink : https://www.aetoswire.com/news/lampt-technology-services-wins-2021-big-innovation-awards-usa/en

Andersen Global Expands Into Russia With Leading Law Firm

 SAN FRANCISCO-Friday 29 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Entering the Russian market, Andersen Global expands its coverage through a Collaboration Agreement with Moscow-based Lidings, a leading independent law firm.

Founded in 2006, the full-service firm works with local and international companies in various industries including market leaders, international investors and medium and large global businesses. Lidings has capabilities in tax, antitrust, banking and finance, employment, restructuring, real estate and litigation with a focus on corporate, disputes and intellectual property. Led by Managing Partner Andrey Zelenin, the law firm is recognized by Chambers and Partners, Legal 500, IFLR1000 and Best Lawyers.

“Over the years, we have built our reputation based on our in-depth knowledge of Russia’s intricate business culture and regulatory framework,” Andrey said. “Our practice has been dynamically growing and collaborating with Andersen Global allows us to better address the evolving business needs of our clients, as well as successfully address their global needs.”

“Andrey and his team bring the type of expertise, stewardship and professionalism that it takes to be leaders in their market,” Andersen Global Chairman and Andersen CEO Mark Vorsatz said. “They are one of the best practices in Russia. The firm’s demonstrated commitment to transparency and proven ability to provide clients with best-in-class solutions complements our global platform.”

Andersen Global is an international association of legally separate, independent member firms comprised of tax and legal professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 7,000 professionals worldwide and a presence in over 242 locations through its member firms and collaborating firms.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005337/en/

Contacts

Megan Tsuei

Andersen Global

415-764-2700

Permalink : https://www.aetoswire.com/news/andersen-global-expands-into-russia-with-leading-law-firm/en

Takeda Presents Positive Results For Mobocertinib in Patients with EGFR Exon20 insertion+ mNSCLC Who Received Prior Platinum-based Chemotherapy

 

CAMBRIDGE, Mass. & OSAKA, Japan -Friday 29 January 2021 [ AETOS Wire ]

Mobocertinib, an oral targeted therapy, demonstrated clinically meaningful responses, with a confirmed objective response rate of 35% as assessed by investigator and 28% as assessed by an independent review committee (IRC)

Responses shown with mobocertinib were durable, with a median duration of response of 17.5 months as assessed by IRC

Results represent encouraging progress in a patient population for which no approved targeted therapies exist

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced new data from the Phase 1/2 trial of mobocertinib (TAK-788) orally administered in previously treated patients with epidermal growth factor receptor (EGFR) Exon20 insertion+ metastatic non-small cell lung cancer (mNSCLC) will be presented as a late-breaking oral session at the International Association for the Study of Lung Cancer (IASLC) 2020 World Conference on Lung Cancer (WCLC) on Friday, January 29 SGT.

“Results show mobocertinib demonstrated clinically meaningful responses and a noteworthy duration of response in patients with EGFR Exon20 insertion+ mNSCLC who received prior platinum-based therapy,” said Pasi A. Jänne, M.D., Ph.D., Dana-Farber Cancer Institute. “These data are promising and provide further evidence for mobocertinib as a potential oral treatment for patients with EGFR Exon20 insertion+ mNSCLC, who are in critical need of targeted treatment options.”

The analysis of platinum-pretreated patients included patients with EGFR Exon20 insertion+ mNSCLC who received prior platinum therapy from the Phase 1/2 trial. All patients were treated at the 160 mg once daily oral dose. Key findings from this population include:

Parameter

Results in Platinum-Pretreated Population (N=114)

Confirmed objective response rate (ORR) per investigator

35% (40/114; 95% CI 26-45)

Confirmed ORR per IRC

28% (32/114; 95% CI 20-37)

Median duration of response (DoR) per IRC

17.5 months (95% CI 7.4-20.3)

Median progression-free survival (PFS) per IRC

7.3 months (95% CI 5.5-9.2)

Disease control rate (DCR) per IRC

78% (89/114; 95% CI 69-85)

The safety profile observed was manageable. The most common treatment-related adverse events (TRAEs; ≥ 20%) in platinum-pretreated patients from the May data cutoff were diarrhea (90%), rash (45%), paronychia (34%), nausea (32%), decreased appetite (32%), dry skin (30%) and vomiting (30%). Grade ≥3 TRAEs (≥5%) included diarrhea (21%). Nineteen patients (17%) discontinued due to AEs, most commonly diarrhea (4%) and nausea (4%). The safety profile from the November data cutoff was consistent with that of the May data cutoff.

“The importance of advancing research for people living with EGFR Exon20 insertion+ mNSCLC – a complex and devastating disease with no approved targeted therapies – cannot be overstated, as existing treatment options provide limited benefit and patients often have poor survival outcomes,” said Christopher Arendt, Head, Oncology Therapeutic Area Unit, Takeda. “We’re proud of these positive results from mobocertinib, the first oral therapy designed to selectively target their disease, and we look forward to submitting data from the platinum-pretreated population analysis to the U.S. Food and Drug Administration (FDA) and other regulatory agencies around the globe.”

Mobocertinib is currently not approved for EGFR Exon20 insertion+ mNSCLC.

Takeda will host a briefing for analysts and investors on Friday, January 29, at 5:00 p.m. ET to discuss these data and the mobocertinib program. Please contact TakedaRandDEvents@fticonsulting.com for further details. Presentation slides and an archived replay of the webcast will be available at https://www.takeda.com/investors/reports/ir-events/.

About the Phase 1/2 Trial

The Phase 1/2 trial aims to evaluate the safety, pharmacokinetics and anti-tumor activity of oral mobocertinib in patients with non-small cell lung cancer (NSCLC). The trial is comprised of a Phase 1 dose-escalation, evaluating mobocertinib as a monotherapy and in combination with chemotherapy, and a Phase 2 expansion, which includes seven different cohorts, as well as an extension cohort, investigating the anti-tumor activity of mobocertinib in various trial populations.

The platinum-pretreated population analysis investigated 114 patients with epidermal growth factor receptor (EGFR) Exon20 insertion+ metastatic NSCLC (mNSCLC) who received prior platinum-based therapy from the escalation and expansion phases of the Phase 1/2 trial and were treated with mobocertinib at the 160 mg once daily dose.

The Phase 2 extension cohort, known as EXCLAIM, investigated 96 previously treated patients with EGFR Exon20 insertion+ mNSCLC who were treated with mobocertinib at the 160 mg once daily dose.

About Mobocertinib (TAK-788)

Mobocertinib, an oral therapy, is a potent, small-molecule tyrosine kinase inhibitor (TKI) specifically designed to selectively target epidermal growth factor receptor (EGFR) Exon20 insertion mutations. In 2019, the U.S. FDA granted mobocertinib Orphan Drug Designation for the treatment of lung cancer with human EGFR 2 (HER2) mutations or EGFR mutations including Exon20 insertion mutations. In April 2020, mobocertinib received Breakthrough Therapy Designation from the FDA for patients with EGFR Exon20 insertion+ metastatic non-small cell lung cancer (mNSCLC) whose disease has progressed on or after platinum-based chemotherapy. In October 2020, mobocertinib was designated as a Breakthrough Therapy in China by the Drug Review Center (CDE) for the same indication.

About EGFR Exon20 Insertion+ mNSCLC

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for approximately 85% of the estimated 1.8 million new cases of lung cancer diagnosed each year worldwide, according to the World Health Organization.1,2 Patients with epidermal growth factor receptor (EGFR) Exon20 insertion+ metastatic NSCLC (mNSCLC) make up approximately 1-2% of patients with NSCLC, and the disease is more common in Asian populations compared to Western populations.3-7 This disease carries a worse prognosis than other EGFR mutations because there are currently no FDA-approved therapies that target Exon20 insertions, and current EGFR TKIs and chemotherapy provide limited benefit for these patients.

Takeda is committed to continuing research and development in EGFR Exon20 insertion+ mNSCLC with the hope of introducing a targeted treatment option for the approximately 30,000 patients diagnosed with the disease worldwide each year.3,4

Takeda’s Commitment to Oncology

Our core R&D mission is to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. Whether it’s with our hematology therapies, our robust pipeline, or solid tumor medicines, we aim to stay both innovative and competitive to bring patients the treatments they need. For more information, visit www.takedaoncology.com.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.

For more information, visit https://www.takeda.com.

Important Notice

For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.

The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.

Forward-Looking Statements

This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could” “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations; the success of or failure of product development programs; decisions of regulatory authorities and the timing thereof; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/reports/sec-filings/ or at www.sec.gov. Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.

1 World Health Organization. Latest Global Cancer Data. https://www.who.int/cancer/PRGlobocanFinal.pdf. Accessed May 11, 2019.

2 American Cancer Society. What is Non-Small Cell Lung Cancer? https://www.cancer.org/cancer/non-small-cell-lung-cancer/about/what-is-non-small-cell-lung-cancer.html.

3 Riess, Jonathan W. Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC. https://www.jto.org/article/S1556-0864(18)30770-6/fulltext. Accessed April 7, 2020.

4 Fang, Wenfeng. BMC Cancer. EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer. https://bmccancer.biomedcentral.com/articles/10.1186/s12885-019-5820-0. Accessed April 7, 2020.

5 Kobayashi Y, Mitsudomi T. Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy. Cancer Sci. 2016;107(9):1179-1186. doi:10.1111/cas.12996

6 Yatabe Y, Kerr KM, Utomo A, et al. EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey. J Thorac Oncol. 2015;10(3):438-445. doi:10.1097/JTO.0000000000000422

7 Kris MG, Johnson BE, Berry LD, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014;311(19):1998-2006. doi:10.1001/jama.2014.3741

Contacts

Media Contacts:

Japanese Media

Kazumi Kobayashi

kazumi.kobayashi@takeda.com

+81 (0) 3-3278-2095

Media outside Japan

Lauren Padovan

lauren.padovan@takeda.com

+1 (617) 444-1419

Permalink : https://www.aetoswire.com/news/takeda-presents-positive-results-for-mobocertinib-in-patients-with-egfr-exon20-insertion-mnsclc-who-received-prior-platinum-based-chemotherapy/en

Cloudreach Launches DevOps as a Service to Provide Flexible Support for Organizations Driving IT Transformation

 

NEW YORK-Thursday 28 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Cloudreach, the leading independent multi-cloud services company, today announced the launch of Cloudreach DevOps as a Service. This new offering combines Cloudreach development and operations, making them available ‘as a Service’ via a simple and flexible subscription model. DevOps as a Service is the first of its kind in the market, and fundamentally changes how cloud IT services are consumed to make it easy for enterprises to adopt cloud native technologies and practices.

Dave Chapman, Head of Strategy and Professional Services at Cloudreach, said: “Cloudreach DevOps as a Service brings a DevOps and cloud engineering skill set to any enterprise, whether they are new to the cloud or far along their modernization journey. Companies that undergo cloud transformation are better able to adapt to disruption, explore and innovate faster. This service helps technology leaders get the right skills in place, at the right time, and scale up and down to suit their changing requirements.”

Cloud acceleration
DevOps is a set of practices that combines software development and IT operations, removing the barriers between these traditionally siloed teams. Under a DevOps model, development and operations teams work together across the entire software application life cycle, from development and test through deployment to operations.

More than a decade after the introduction of cloud computing, many enterprises still find themselves suffering from the symptoms of legacy IT and legacy partners. Cloudreach DevOps as a Service makes cloud outsourcing easy by providing flexible engineering squads as a monthly subscription service. The new offering is designed to help technology leaders accelerate their cloud initiatives, embrace true DevOps within their teams, and help their organizations become more cloud native.

Cloudreach DevOps as a Service provides a core DevOps team that can be augmented to perform architecture, platform development, data engineering, application UX and product management roles, all as a unified service. As business priorities or backlogs change, the flexible nature of the service means customers can swap out squad members and scale the team up and down as needed, within a single statement of work. The minimum squad size includes two resources and 80 hours per month, with a minimum contract commitment of three months.

Cloudreach squads have a radical focus on trend improvement and platform evolution. They can help launch new products, accelerate and scale business initiatives, facilitate stronger collaboration with digital teams, or support key applications and infrastructure.

James Dunn, Head of Cloud Platform Development at Cloudreach, said: “Over its 10-year history, Cloudreach has delivered some of the largest and most successful cloud engineering projects in the world. Now we are bringing Cloudreach's cloud native expertise to market in a flexible subscription model.”

About Cloudreach
Cloudreach is a leading independent cloud services company. Our mission is to deliver the promise of cloud and drive extraordinary value for our customers. Cloudreach helps enterprises win competitive advantage through successful cloud transformation.

With more than 10 years of cloud native experience, we've built an unmatched depth and breadth of expertise in cloud technologies and their application to business. For more information about our services, visit cloudreach.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210128005535/en/

Contacts

Rahim Hakimi
Email: rahim.hakimi@cloudreach.com


Permalink : https://www.aetoswire.com/news/cloudreach-launches-devops-as-a-service-to-provide-flexible-support-for-organizations-driving-it-transformation/en

Esri Launches ArcGIS Platform

  Comprehensive Location Services, Data, and Mapping Tools Are Available to Developers

REDLANDS, Calif.-Thursday 28 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Esri, the global leader in location intelligence, today announced the launch of ArcGIS Platform, a geospatial platform as a service (PaaS) for developers that need to integrate location capabilities into their apps, business systems, and products. ArcGIS Platform gives developers direct access to Esri's powerful location services using the APIs and web frameworks of their choice.

"ArcGIS Platform lets users build their own products or integrate Esri services into existing software," said Jack Dangermond, Esri founder and president. "This PaaS makes it easier for software developers to access geospatial technology."

"With the release of ArcGIS Platform, developers now have access to professional-grade content and capabilities they can readily plug into their apps, allowing them to stay on budget while delivering enormous value by reducing time to market," said David Cardella, Esri product manager for developer technologies.

Scaling with developers and their apps, ArcGIS Platform lets customers leverage the same framework and services whether they're supporting dozens of users or millions of them.

"We're excited our partnership with Esri has continued with the integration of ArcGIS Platform," said Ben Brantly, VP of product at Salesforce. "Esri's collection of ready-to-use basemaps gives our users a solution to better understand their data by presenting it visually on a map. The capabilities of ArcGIS Platform allow us to continue to expand the value we provide to Salesforce Maps users by leveraging additional Esri location services as well as the adoption of the ArcGIS API for JavaScript."

Esri is unveiling ArcGIS Platform at a virtual event today, where users like Salesforce and cloud-based drone management capability provider Airspace Link are speaking about how they use Esri's PaaS technology.

"Fused with local data, Esri's demographic and geocoding services help us deliver a product that promotes safe, compliant drone operations for our customers across the country," said Airspace Link Cofounder, President, and CEO Michael Healander.

Longtime Esri partner, SAP, is also featured in the launch event. “Location services from Esri’s ArcGIS Platform will be exposed through SAP’s cloud consumption model, which plays to the strength of what customers are looking for,” said Irfan Khan, President for Platform &Technology at SAP. “SAP’s Business Technology Platform provides an ideal integration point, allowing developers to more easily build innovative applications that combine real-time business data with geospatial intelligence.”

To learn more about Esri, a leader in The Forrester Wave™: Location Intelligence Platforms, Q2 2020, and ArcGIS Platform and how it delivers low-cost, high-quality location services to developers, visit go.esri.com/Platform-Learn-More.

About Esri

Esri, the global market leader in geographic information system (GIS) software, location intelligence, and mapping, helps customers unlock the full potential of data to improve operational and business results. Founded in 1969 in Redlands, California, USA, Esri software is deployed in more than 350,000 organizations globally and in over 200,000 institutions in the Americas, Asia and the Pacific, Europe, Africa, and the Middle East, including Fortune 500 companies, government agencies, nonprofits, and universities. Esri has regional offices, international distributors, and partners providing local support in over 100 countries on six continents. With its pioneering commitment to geospatial information technology, Esri engineers the most innovative solutions for digital transformation, the Internet of Things (IoT), and advanced analytics. Visit us at esri.com.

Copyright © 2021 Esri. All rights reserved. Esri, the Esri globe logo, ArcGIS, The Science of Where, esri.com, and @esri.com are trademarks, service marks, or registered marks of Esri in the United States, the European Community, or certain other jurisdictions. Other companies and products or services mentioned herein may be trademarks, service marks, or registered marks of their respective mark owners.

Additional Quotes

“Esri’s location services integrate easily with Autodesk – together we’re changing the way the industry works.”
Theo Angelopoulos, Senior Director, Infrastructure Business Strategy & marketing, Autodesk

“With the launch of Esri’s new location platform, we look forward to accessing a greater number of services with more flexibility to make our offerings even more meaningful.”
George Mastakas, VP Enterprise Solutions and Corporate Partnerships, CityWorks

“Reliable, scalable location services from Esri allow us to focus on delivering innovative solutions.”
Brian J. Smith, Senior Vice President, GeoDecisions – A Division of Gannett-Fleming, Inc.

“The flexibility, increased speed, and variety of mapping and imagery layers gives our users unprecedented control over their risk assessments.”
John Goolgasian, Chief Operating Officer, Geospark Analytics

“We rely on Esri location services to provide scalable, tailored solutions for our customers.”
Steve Mulberry, Geospatial Innovation Strategist, GISinc

“With the seemingly endless capabilities provided by Esri location services, K&A can quickly and effectively integrate location intelligence into our solutions and our clients’ business workflows for an improved customer experience.”
Walid Abou Chacra, Manager, Electricity Segment, Khatib & Alami

“We highly recommend Esri location services as the premier technology to help utilities optimize their network for the future.”
Chris Erpelding, GIS Consulting Department Manager, POWER Engineers

“Esri location services enables Schneider Electric to build world class solutions that manage the lifecycle of the Utility Network.”
Jay Stinson, Vice President, Digital Grid Asset Management Business, Schneider Electric

“The newest ArcGIS Platform architecture enables us to provide solutions embedding advanced spatial capabilities to our customers faster and easier than ever before.”
Signe Bramming Andersen, Director of Business Development, Similix

“Esri location services provide flexibility in our programs and products, and expands the value of GIS for our customers.”
Adam Tonkin, CTO, SSP Innovations

“Esri’s location services are a crucial component of Cartegraph’s mission to optimize the productive life of every infrastructure asset – indoors, outdoors, above and below ground.”
Josh Mallamud, CEO, Cartegraph

“When our customers need to provision high-precision apps for offline field work with Geocortex Mobile, or publish modern mapping apps with all the tools tailored for their staff’s needs, they rely on Geocortex and ArcGIS Platform to take those apps to the next level.”
Jon Brooks, CEO, VertiGIS

View source version on businesswire.com: https://www.businesswire.com/news/home/20210127005050/en/

Contacts

Jo Ann Pruchniewski
Public Relations, Esri
Mobile: 301-693-2643
Email: jpruchniewski@esri.com


Permalink : https://www.aetoswire.com/news/esri-launches-arcgis-platform/en

C3 AI Reinvents No Code AI with the Introduction of C3 AI Ex Machina

  New C3 AI Ex Machina is the Only No-Code Solution That Anyone Can Use to Generate Actionable AI-Based Insights

REDWOOD CITY, Calif.-Thursday 28 January 2021 [ AETOS Wire ]

(BUSINESS WIRE) -- C3 AI (NYSE: AI), the world’s leading provider of enterprise AI software, today announced the general availability of C3 AI® Ex Machina, a next-generation predictive analytics application that empowers anyone to develop, scale, and produce AI-based insights without writing code.

Analysts, operators, and subject matter experts across all industries and business functions are increasingly required to develop predictive and prescriptive insights compiled from vast and disparate datasets. While there are many no-code tools available that lower the barrier for users to build ML models and perform data analysis, none provide end-to-end capabilities that enable them to capture and process the volume and variety of data required, automatically generate interpretable AI models, and productize, deploy, and scale the results across their company. Current predictive analytics tools are typically complicated to use and limit the ability of their insights to drive real business outcomes.

C3 AI Ex Machina is the only end-to-end, no-code predictive analytics solution that enables individuals, teams, and enterprises to:

    Rapidly and flexibly access and prep petabytes of disparate data with prebuilt connectors to data sources such as Snowflake, S3, ADLS, Databricks, and more.

    Build and manage AI models without writing code using an intuitive drag-and-drop interface supported by powerful AutoML.

    Drive company-wide results by seamlessly publishing predictive insights to enterprise systems or custom business applications.

    Scale cloud resources to meet needs in a modern, cloud-native application while only paying for resources used.

    Grow with confidence by integrating and expanding on the C3 AI Suite, the platform that powers billions of AI predictions for the world’s largest companies.

Con Edison’s data analysts use C3 AI Ex Machina to identify malfunctioning meters in near-real-time, realizing significant business value. "C3 AI Ex Machina empowers our analysts to easily harness all our data and assess reliability and safety risks. Our AMI Operations group recently used C3 AI Ex Machina to build predictive models that identified hazardous electric meters at risk of overheating. Using C3 AI Ex Machina, our business analysts are now able to evaluate near-real-time risk scores and immediately schedule prioritized field inspections,” said Chris Brownlee, Department Manager at Con Edison. “C3 AI Ex Machina has dramatically simplified and accelerated our ability to build and deploy machine learning models to address use cases that proactively identify risks and provide safer, more reliable service to our customers.”

C3 AI Ex Machina enables anyone to apply the power of predictive analytics to their business and play a role in the increasing digitization of company operations. The application allows users to solve a limitless range of complex use cases, including customer churn prevention, supplier delay mitigation, asset reliability prediction, and fraud detection – all supported by the robust platform enterprise AI capabilities of the C3 AI Suite.

“C3 AI Ex Machina enables anyone to combine their business expertise with no-code AI to deliver predictive insights that their company can take informed action against,” said C3 AI President and CTO Ed Abbo. “C3 Ex Machina offers a tried, tested, and proven path to rapid enterprise AI application development and deployment. It empowers anyone with subject matter expertise to significantly improve their organization’s ability to make timely and contextual data-driven decisions.”

Learn more about C3 AI Ex Machina and try the application at https://c3.ai/products/c3-ai-ex-machina/.

About C3 AI

C3 AI (NYSE:AI) is a leading provider of Enterprise AI software for accelerating digital transformation. C3 AI delivers a family of fully integrated products: C3 AI® Suite, an end-to-end platform for developing, deploying, and operating large-scale AI applications; C3 AI Applications, a portfolio of industry-specific SaaS AI applications; C3 AI CRM, a suite of industry-specific CRM applications designed for AI and machine learning; and C3 AI Ex Machina, a no-code AI solution to apply data science to everyday business problems. The core of the C3 AI offering is an open, model-driven AI architecture that dramatically simplifies data science and application development. Learn more at: www.c3.ai

View source version on businesswire.com: https://www.businesswire.com/news/home/20210127005302/en/

Contacts

C3 AI Public Relations
Edelman
Lisa Kennedy
415-914-8336
pr@c3.ai

Investor Relations
IR@C3.ai


Permalink : https://www.aetoswire.com/news/c3-ai-reinvents-no-code-ai-with-the-introduction-of-c3-ai-ex-machina/en